TNFRSF11A and acute myeloid leukemia: To study whether RANK expression correlates with survival of AML patients, we grouped patients into quartiles according to the proportion of RANK+ cells (Figure 4G) or SFI levels (Figure 4H) and assessed overall survival (OS) in each group using Kaplan-Meier analysis.